John Dougherty, MD
Geriatric Medicine · Oro Valley, AZNPI 1043252844
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 90 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Amgen at 31.0% of the total. Reporting peaked in 2019 at $404 and has fallen 74.7% since, to $102 in 2025.
Across 90 payments — averaging $14.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$403
- Novo Nordisk$177
- Novartis$130
- Radius Health, Inc.$80
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$69
- Lilly USA, LLC$60
- plus $379 from 14 others
What the payments were for
- Food & beverage$1,299100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 26 | $403 |
| Novo Nordisk | 20 | $177 |
| Novartis | 7 | $130 |
| Radius Health, Inc. | 5 | $80 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $69 |
| Lilly USA, LLC | 4 | $60 |
| AbbVie | 3 | $56 |
| AstraZeneca | 4 | $53 |
| Amarin Pharma, Inc. | 3 | $50 |
| Boston Scientific | 1 | $39 |
| Johnson & Johnson | 2 | $31 |
| Pfizer | 2 | $26 |
| Lundbeck LLC | 1 | $23 |
| Sunovion Pharmaceuticals Inc. | 1 | $18 |
| Arbor Pharmaceuticals, Inc. | 1 | $17 |
| Genentech USA, Inc. | 1 | $15 |
| Nestle Healthcare Nutrition Inc. | 1 | $13 |
| Alfasigma USA, Inc. | 1 | $13 |
| Boehringer Ingelheim | 1 | $13 |
| Amneal Pharmaceuticals LLC | 1 | $13 |
How this compares
$1,299 in reported general payments places this provider in the 80th percentile of 75 geriatric medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 63 | $107,660 |
| EliquisApixaban | 37 | $60,095 |
| XareltoRivaroxaban | 33 | $51,100 |
| Repatha SureclickEvolocumab | 31 | $49,045 |
| Rosuvastatin Calcium | 402 | $6,529 |
| Valsartan | 151 | $3,859 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 13 | $2,677 |
| Losartan Potassium | 141 | $2,104 |
| Memantine Hcl | 18 | $1,600 |
| Levothyroxine Sodium | 122 | $1,541 |
| Amlodipine Besylate | 211 | $1,446 |
| Pantoprazole Sodium | 94 | $1,436 |
| Tamsulosin Hcl | 79 | $1,382 |
| Azelastine Hcl | 43 | $1,365 |
| Pregabalin | 70 | $1,207 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $177 | $107,66063 claims |
| PfizerEliquis | $26 | $60,09537 claims |
| Johnson & JohnsonXarelto | $31 | $51,10033 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $13 | $1,541122 claims |
| AbbVieSynthroid | $56 | $80719 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 75 geriatric medicine providers in Arizona.
Other geriatric medicine in Oro Valley
- John MiglianoTucson$100K
- Robin MacdougallPhoenix$51K
- John HomanTucson$18K
- Raghav MohindraPrescott Valley$16K
- Albert RuttingerSurprise$11K
- Rikesh DesaiSurprise$8K
- Aureliano CifuentesTempe$8K
- Ramakrishnan SubbureddiarTucson$7K
- Anil NandaPhoenix$4K
- Scott BernsteinScottsdale$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.